Latest pharma Update... Sep 06
Breakthrough in Hepatocellular Cancer ; Milciclib granted patent... Aug 25
On the ground testing in China has revealed anti-IL6R mAbs, currently approved for rheumatoid arthritis, has a role to play in treating patients. ... Mar 12
-Advertisements-